Nrx Pharmaceuticals (NRXPW) Stock Price, News & Analysis
Company Description
Nrx Pharmaceuticals (NASDAQ: NRXPW) is a publicly traded company in the Pharmaceutical Preparations sector.
NRXPW stock has declined 96.6% over the past year. Shares last traded at $0.0026.
On a trailing twelve-month basis, Nrx Pharmaceuticals reported revenue of $1.2M with net income of -$28.6M. The company operates at a net profit margin of -2336.5%.
This page provides a comprehensive overview of NRXPW stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Nrx Pharmaceuticals (NRXPW) stock last traded at $0.0026. Over the past 12 months, the stock has lost 96.6%.
NRXPW Rankings
Latest News
SEC Filings
Nrx Pharmaceuticals has filed 5 recent SEC filings, including 2 Form 8-K, 2 Form 424B5, 1 Form 25-NSE. The most recent filing was submitted on June 4, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NRXPW SEC filings →
Financial Highlights
Nrx Pharmaceuticals generated $1.2M in revenue over the trailing twelve months, retaining a 58.8% gross margin, operating income reached -$16.2M (-1324.4% operating margin), and net income was -$28.6M, reflecting a -2336.5% net profit margin. The company generated -$14.1M in operating cash flow. With a current ratio of 0.31, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Nrx Pharmaceuticals (NRXPW) currently stands at 5.2 thousand shares, down 83.1% from the previous reporting period.
Days to Cover History
Days to cover for Nrx Pharmaceuticals (NRXPW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
NRXPW Company Profile & Sector Positioning
Nrx Pharmaceuticals (NRXPW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.